FDA Investigator Sandra A Boyd

Sandra A Boyd has inspections in 6 countries as of 18 Oct 2023. Sandra A Boyd has collaborated with a combinined 5464 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
25
Last Inspection Date:
18 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100004034
Country:
India, United States of America, New Zealand, Australia, France, Spain
Co-Investigator(s):
Adetutu M Gidado, Aditi S Thakur, Adree N Anderson, Alex M Viehmann, Amanda S Zorn, Amir A Abdalla, Anastasia M Shields, Andrace Lde Yampert, Andrea D Swingle, Anita Narula, PhD, Annemarie Bodnar, Anthony R Bucks, Anthony R Petriella, April P Shaw, Arsen Karapetyan, Azza Talaat, Barbara J Rincon, Barbara Jwilimczyk Macri, Bei Y He, Benjamin J Smith, Bichsa T Nguyen, Bichsa T Tran, Binh T Nguyen, Blondell W Johnson, Bonita S Chester, Brian D Nicholson, Brian L Szcyubialka, Byungja E Marciante, Carla J Lundi, Carmen M Faraianu, Carol A Gripp, Caroline H Le, Carr Sharpe, Carrie A Hughes, Carrie Ann Plucinski, Caryn M Mcnab, Cassandra L Abellard, Charles I Ann, Charles L Zhou, Charles R Cote, RIC, Cheryl A Clausen, Cheryl A Fuhs, Cheryl M Monroe, Christopher D Leach, Christopher S Keating, Cody J Alley, Concannon, Constantin Y Philopoulos, Corrine M Carter, Cristina Ausin Moreno, PhD, Cristina Ausin Moreoo, PhD, Cynthia Jim, CSO, Daniel J Brown, Darren S Morgan, David A Oluwo, David A Paterson, David Perkins, Dawn C Olenjack, Debara R Reese, Debara Reese, Deborah A Greco, Debra I Love, Denise L Burosh, Dennis Cantellops Paite, Dennis E Guilfoyle, PhD, Diane L Raccasi, Dina A Tallman, Donald C Obenhuber, PhD, Douglas C Kovacs, Dr. Robert C Horan, MD, Eboni S Funderburk, Edward E Lockwood (EEL), Edwin Jao, Emest F Bizjak, Emilie E Kahn, Emily J Orban, Eric M Mueller, PharmD, Eric M Padgett, Erika V Butler, Esther C Broner, PhD, Felix Maldonado, Frank Wackes, Geneve M Maxwell, Georgia A Layloff, Gloria J Champagne, Gregory W Smith, Gregson A Joseph, Guo Q Shen, Gwyn G Dickinson, Himanshu Gupta, PhD, Hyung Yul Lee, Ismael Oera Lv, Ismael Olvera, IV, Ivy E Sweeney, Jacob G Lutz, Jacob W Reynolds, James A Lane, James C Maclaughlin, James D Planchon, James I Giefer, James K Ireland, James P Mcreavey, James W Plucinski, Janet A Rajan, Jason F Chancey, Jean Blackston Hill, Jean Blackstone Hill, Jeffrey A Sommers, Jeffrey D Meng, Jeffrey P Raimondi, Jennifer A Kemp, Jennifer Guttuso, Jennifer M Gogley, Jessica E Hensley, Jimmie L Weigand, Joel D Hustedt, Jogy George, John A Gonzalez, John C Mcmichael, Jolanna A Norton, Jon P Antoniou, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose M Cayuela, Joseph A Piechocki, Joseph R Lambert, Joseph R Strelnik, Joslyn K Brunelle, PhD, Juandria Williams, Julia Ventura, Junho Pak, Justin A Boyd, Kara L Roden, Karen C Daugherty, Karen E D'orazio, Karen M Montgomery (KMM), Karishma G Gopaul, Karthik B Iyer, Katherine D Adams, Katherine Szestypalow, Kathleen B Swat, Kathleen M Bradley, Kellia N Hicks, Kevin P Regan, Kham Phommachanh, Kim Lthomas Cruse, Ko U Min, L'oreal F Walker, Lakecha N Lewis, Larry K Austin, Lata C Mathew, PhD, Lauren Iacono Connors, PhD, Lauren L Vajo, LCDR Michael H Tollon, LCDR Sean Byrd, Lee, Leigh Anne Myers, Lequita M Mayhew, Leslie A Paul, Libia M Lugo, Linda F Murphy, Lisa C Lewis, Lisa L Flores, Lisa M Bellows, Logan T Williams, Loretta J Jordan, Lori B Wikstrom, Luella J Rossi, Mai X Huynh, Marcus F Yambot, Margaret A Smithers, Maria Cruz Fisher, Maria I Cruz Fisher, Marianela Aponte Cruz, Marion D Wimberly, Jr, Mark C Saale, Mark R Mcclain, Martha Sullivan Mynck, Martha Sullivan Myrick, Mary K Concannon, Matthew B Casale, Matthew H Hunt, Matthew Ondeck, Maurice M Sheehan, Meisha R Sampson, Meisha Waters, Melina Rodriguez Upton, Mercy Oyugi, Michael A Charles, Michael A Taylor, Michael D Garcia, Michael E Maselli, Michael L Casner, Michael L Chasey, Michael R Goga, Michael Shanks, MS, Michael Y Philopoulos, Michele L Forster, PhD, Michele L Glendenning, Michele L Obert, Michele Perry Williams, Minerva Rogers, Montgomery Montgomery, Karen M, Muna Algharibeh, Muna Alghribeh, Myra K Casey, Nadeem I Chaudhry, Nailing Zhang, Nancy F Scheraga, Nancy G Schmidt, Nancy M Espinal, Nancy Sheraga, Neali H Lucas, Nibin Varghese, MS, Nicholas A Violand, Nicholas F Lyons, Nicholas L Hunt, Nicholas L Paulin, Norman K Starks, Parul M Patel, Patricia A Cochran, Patricia H Dlugosz, Patrick B Cummings, Patrick L Wisor, Patsy J Domingo, Paul L Bellamy, Philip F Istafanos, DMV, MS, Phillip M Pontikos, Phung Thien Nguyen, Qiao Y Bobo, Rabia Ballica, PhD, Rabin N Ghoshal, Rafeeq A Habeeb, Ramon A Hernandez, Randy L Self, Raymond T Oji, Rebecca E Dombrowski, Regina T Brown, Richmond K Yip, Rick L Friedman, Robert Barbosa, Robert D Tollefsen, Robert J Ham, Robert M Barbosa, Rodney D Combs, Rohit B Kolhatkar, Rumany C Penn, PharmD, Russell J Glapion, Russell K Riley, S Lori Brown, PhD MPH, Saied A Asbagh, Saleem A Akhtar, Sandra A Hughes, Sandra D Wilson Newby, Sangeeta M Khurana, PhD, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Sargum C Sood, Scott B Laufenberg, Scott R Nichols, PhD, Sean R Bryd, Sena G Dissmeyer, Sherry G Bous, Shirley J Berryman, Shirley S Wen, Sidney B Priesmeyer, Sneha S Patel, Srinivas R Chennamaneni, PhD, State Agency, Steven D Kehoe, Susan F Laska, MS, Susan P Bruederle, Susanna E Ford, Analyst, Suyang Qin, Tajah L Blackburn, Tara G Bizjak, Thomas J Arista, Thuy T Nguyen, LCDR, Timothy J Schmidt, Tina M Pawlowski, Todd M Stankewicz, Tracey Asinjen Wiersma, Truong Xuan Nguyen (Andy), Ucheabuchi C Chudi Nwankwor, Unnee Ranjan, Uttaniti Limchumroon (Tom), Vaishali J Patel, Veronica Fuentes, MS, Veronica L Call, Walden H Lee, Warren J Lopicka, Wayne D Mcgrath, Wayne E Seifert, William D Tingley, Yangmin Ning, Yanming An, PhD, Yumi J Hiramine, Yvesna C Blaise, Yvonne E Lozano, Zachary A Bogorad, Zedong Dong, Zhongren Wu

Sandra A Boyd's Documents

Publish Date Document Type Title
October, 2023 FDA 483 PANACEA BIOTEC PHARMA LIMITED - Form 483, 2023-10-12
October, 2019 FDA 483 Douglas Manufacturing Limited - Form 483, 2019-10-11
January, 2019 FDA 483 L. Perrigo Company - Form 483, 2019-01-17
September, 2021 FDA 483 Response GSK Consumer Health, Inc. - Form 483R, 2021-10-21
January, 2023 FDA 483 Centaur Pharmaceuticals Private Limited - Form 483, 2023-01-13
September, 2022 FDA 483 Catalent Indiana, LLC - Form 483, 2022-09-01
December, 2022 FDA 483 Galentic Pharma (India) Private Limited - Form 483, 2022-12-08
September, 2021 FDA 483 GSK Consumer Health, Inc. - Form 483, 2021-09-30
March, 2021 FDA 483 Response Eli Lilly and Company - Form 483R, 2021-04-06
June, 2019 FDA 483 Response Meridian Medical Technologies, LLC - Form 483R, 2019-06-27
March, 2022 FDA 483 Novel Laboratories, Inc. - Form 483, 2022-03-30
March, 2019 FDA 483 Glenmark Pharmaceuticals Limited - Form 483, 2019-03-15
March, 2020 FDA 483 Kendrick Laboratories, Inc. - Form 483, 2020-03-10
March, 2019 FDA 483 MARKSANS PHARMA LIMITED - Form 483, 2019-03-05
November, 2018 FDA 483 Agnitio Inc. - Form 483, 2018-11-09
March, 2021 FDA 483 Eli Lilly and Company - Form 483, 2021-03-16
October, 2018 FDA 483 True Botanica, LLC - Form 483, 2018-10-26
September, 2022 EIR Catalent Indiana, LLC - EIR, 2022-09-01
October, 2022 FDA 483 Recipharm Monts - Form 483, 2022-10-18
June, 2019 FDA 483 Meridian Medical Technologies, LLC - Form 483, 2019-06-06
January, 2023 FDA 483 INDOCO REMEDIES LIMITED - Form 483, 2023-01-20
October, 2019 FDA 483 Morton Grove Pharmaceuticals, Inc. - Form 483, 2019-10-31

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more